Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2004

01-05-2004 | Clinical Investigation

Glaucoma and mortality

Authors: Kirsti Grødum, Anders Heijl, Bo Bengtsson

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 5/2004

Login to get access

Abstract

Purpose

To compare mortality rates in glaucoma patients and matched controls from a large population screening as well as glaucoma patients diagnosed through routine clinical examination (self-selected patients).

Methods

A population-based screening of 32,918 elderly citizens of Malmö was conducted between 1992 and 1997. Individuals with newly detected, previously untreated open-angle glaucoma were identified. Two controls of the same age and gender were chosen among the screening negative participants for each patient. From the same birth cohorts, glaucoma patients seen in routine clinical practice (self-selected patients) were identified through retrospective examination of patient records from the Eye Department at Malmö University Hospital. The number and time of deaths for each group were determined based on centrally administered registers.

Results

Mean follow-up time was 7.75 years. Five-year mortality did not differ significantly between the groups, and was 9.2% among glaucoma patients from the screening (n=402), and 11.9% among the controls (n=804; p=0.7406). Self-selected glaucoma patients had a 5-year mortality of 8.5% (n=354), not significantly different from the screening-detected glaucoma patients (p=0.1361). Among glaucoma patients, neither IOP (p=0.1781) nor pseudoexfoliation (p=0.8882) was related to significantly increased mortality.

Conclusions

The results of this study strongly suggest that the life expectancy of glaucoma patients does not differ from the population at large.
Literature
1.
go back to reference Anderson DR (1989) Glaucoma: the damage caused by pressure.XLVI Edward Jackson memorial lecture. Am J Ophthalmol 108:485–495PubMed Anderson DR (1989) Glaucoma: the damage caused by pressure.XLVI Edward Jackson memorial lecture. Am J Ophthalmol 108:485–495PubMed
2.
go back to reference Åsman P, Heijl A (1992a) Evaluation of methods for automated hemifield analysis in perimetry. Arch Ophthalmol 10:820–826 Åsman P, Heijl A (1992a) Evaluation of methods for automated hemifield analysis in perimetry. Arch Ophthalmol 10:820–826
3.
go back to reference Åsman, Heijl A (1992b) Glaucoma Hemifield Test: automated visual field evaluation. Arch Ophthalmol 10:812–819 Åsman, Heijl A (1992b) Glaucoma Hemifield Test: automated visual field evaluation. Arch Ophthalmol 10:812–819
4.
go back to reference Bengtsson B (1984) Survival of elderly ophthalmic out-patients. Acta Ophthalmol Scand 62:725–730 Bengtsson B (1984) Survival of elderly ophthalmic out-patients. Acta Ophthalmol Scand 62:725–730
5.
go back to reference Borger PH, Van Leeuwen R, Hulsman CAA et al. (2003) Is there a direct association between age-related eye disease and mortality? Ophthalmology 110:1292–1296CrossRefPubMed Borger PH, Van Leeuwen R, Hulsman CAA et al. (2003) Is there a direct association between age-related eye disease and mortality? Ophthalmology 110:1292–1296CrossRefPubMed
6.
go back to reference Chung HS, Harris A, Evans DW et al. (1999) Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol 43:S43–S50CrossRefPubMed Chung HS, Harris A, Evans DW et al. (1999) Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol 43:S43–S50CrossRefPubMed
7.
go back to reference Cox DR (1972) Regression models and life tables. J R Stat Soc B 30:187–202 Cox DR (1972) Regression models and life tables. J R Stat Soc B 30:187–202
8.
go back to reference Diggory P, Franks W (1996) Medical treatment of glaucoma: a reappraisal of the risks. Br J Ophthalmol 80:85–89PubMed Diggory P, Franks W (1996) Medical treatment of glaucoma: a reappraisal of the risks. Br J Ophthalmol 80:85–89PubMed
9.
go back to reference Drance SM, Sweeney VP, Morgan RW et al (1973) Studies of factors involved in the production of low-tension glaucoma. Arch Ophthalmol 89:457–465PubMed Drance SM, Sweeney VP, Morgan RW et al (1973) Studies of factors involved in the production of low-tension glaucoma. Arch Ophthalmol 89:457–465PubMed
10.
go back to reference Egge K, Zahl PH (1999) Survival of glaucoma patients. Acta Ophthalmol Scand 77:397–401PubMed Egge K, Zahl PH (1999) Survival of glaucoma patients. Acta Ophthalmol Scand 77:397–401PubMed
11.
go back to reference Flammer J, Gasser P, Prünte C et al. (1992) The probable involvement of factors other than ocular pressure in the pathogenesis of glaucoma. Pharmacol Glaucoma 273–283 Flammer J, Gasser P, Prünte C et al. (1992) The probable involvement of factors other than ocular pressure in the pathogenesis of glaucoma. Pharmacol Glaucoma 273–283
12.
go back to reference Grødum K, Heijl A, Bengtsson B (2002) A comparison of glaucoma patients identified through mass screening and in routine clinical practice. Acta Ophthal Scand 80:627–631CrossRef Grødum K, Heijl A, Bengtsson B (2002) A comparison of glaucoma patients identified through mass screening and in routine clinical practice. Acta Ophthal Scand 80:627–631CrossRef
13.
go back to reference Gupta N, Weinreib R (1997) New definitions of glaucoma. Curr Opin Ophthalmol 8:38–41PubMed Gupta N, Weinreib R (1997) New definitions of glaucoma. Curr Opin Ophthalmol 8:38–41PubMed
14.
go back to reference Harrison R, Kaufmann CS (1977) Clonidine: effects of a topically administered solution on intraocular pressure and blood pressure in open-angle glaucoma. Arch Ophthalmol 95:1368–1373PubMed Harrison R, Kaufmann CS (1977) Clonidine: effects of a topically administered solution on intraocular pressure and blood pressure in open-angle glaucoma. Arch Ophthalmol 95:1368–1373PubMed
15.
go back to reference Hayreh SS, Zimmerman BM, Podhajsky P et al. (1994) Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117:603–624PubMed Hayreh SS, Zimmerman BM, Podhajsky P et al. (1994) Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117:603–624PubMed
16.
go back to reference Heijl A, Leske MC, Bengtsson B et al. (2002) Reduction of intraocular pressure and glaucoma progression. Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268–1278PubMed Heijl A, Leske MC, Bengtsson B et al. (2002) Reduction of intraocular pressure and glaucoma progression. Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268–1278PubMed
17.
go back to reference Hennis A, Wu SY, Nemesure B et al. (2003) Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology 110:908–914CrossRefPubMed Hennis A, Wu SY, Nemesure B et al. (2003) Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology 110:908–914CrossRefPubMed
18.
go back to reference Hietanen J, Soisalon-Soininen S, Kivela T et al. (2002) Evaluation of the clinical association between exfoliation syndrome and abdominal aortic aneurysm. Acta Ophthalmol Scand 80:617–619CrossRefPubMed Hietanen J, Soisalon-Soininen S, Kivela T et al. (2002) Evaluation of the clinical association between exfoliation syndrome and abdominal aortic aneurysm. Acta Ophthalmol Scand 80:617–619CrossRefPubMed
19.
go back to reference Hiller R, Podgor MJ, Sperduto RD et al. (1999) High introcular pressure and survival: the Framingham Studies. Am J Ophthalmol 128:440–445CrossRefPubMed Hiller R, Podgor MJ, Sperduto RD et al. (1999) High introcular pressure and survival: the Framingham Studies. Am J Ophthalmol 128:440–445CrossRefPubMed
20.
go back to reference Hodapp E, Kolker AE, Kass MA et al. (1981) The effect of topical clonidine on intraocular pressure. Arch Ophthalmol 99:1208–1211PubMed Hodapp E, Kolker AE, Kass MA et al. (1981) The effect of topical clonidine on intraocular pressure. Arch Ophthalmol 99:1208–1211PubMed
21.
go back to reference Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481 Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481
22.
go back to reference Kass MA, Heuer DK, Higginbotham EJ et al. (2002) The Ocular Hyperrtension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701–713PubMed Kass MA, Heuer DK, Higginbotham EJ et al. (2002) The Ocular Hyperrtension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701–713PubMed
23.
go back to reference Klein R, Klein BEK, Moss SE (1995) Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 113:333–339PubMed Klein R, Klein BEK, Moss SE (1995) Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 113:333–339PubMed
24.
go back to reference Lee DJ, Gómez-Marín O, Lam BL et al. (2003) Glaucoma and survival. The National Health Interview Survey 1986–1994. Ophthalmology 110:1476–1483CrossRefPubMed Lee DJ, Gómez-Marín O, Lam BL et al. (2003) Glaucoma and survival. The National Health Interview Survey 1986–1994. Ophthalmology 110:1476–1483CrossRefPubMed
25.
go back to reference Leske C, Heijl A, Hyman L et al (1999) Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106:2144–2153PubMed Leske C, Heijl A, Hyman L et al (1999) Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106:2144–2153PubMed
26.
go back to reference Leske MC (2003) Glaucoma and mortality: A connection? Guest editorial. Ophthalmology 110:1473–1475CrossRefPubMed Leske MC (2003) Glaucoma and mortality: A connection? Guest editorial. Ophthalmology 110:1473–1475CrossRefPubMed
27.
go back to reference Mitchell P, Smith W, Chey T et al. (1997) Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology 104:712–718PubMed Mitchell P, Smith W, Chey T et al. (1997) Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology 104:712–718PubMed
28.
go back to reference Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124:685–687PubMed Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124:685–687PubMed
29.
go back to reference Odberg T (1993) Visual field prognosis in early glaucoma: a long-term clinical follow-up. Acta Ophthalmol Scand 71:721–726 Odberg T (1993) Visual field prognosis in early glaucoma: a long-term clinical follow-up. Acta Ophthalmol Scand 71:721–726
30.
go back to reference Odberg T, Jakobsen JE, Hultgren SJ et al. (2001) The impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaire. Acta Ophthalmol Scand 79:116–120CrossRefPubMed Odberg T, Jakobsen JE, Hultgren SJ et al. (2001) The impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaire. Acta Ophthalmol Scand 79:116–120CrossRefPubMed
31.
go back to reference Repo L, Teräsvirta, Koivisto KJ (1993) Generalized transluminance of the iris and the frequency of the pseudoexfoliation syndrome in the eyes of transient ischemic attack patients. Ophthalmology 100:352–355PubMed Repo L, Teräsvirta, Koivisto KJ (1993) Generalized transluminance of the iris and the frequency of the pseudoexfoliation syndrome in the eyes of transient ischemic attack patients. Ophthalmology 100:352–355PubMed
32.
go back to reference Ringvold A, Blika S, Sandvik L (1997) Pseudo-exfoliation and mortality. Acta Ophthalmol Scand 75:255–256PubMed Ringvold A, Blika S, Sandvik L (1997) Pseudo-exfoliation and mortality. Acta Ophthalmol Scand 75:255–256PubMed
33.
34.
go back to reference Schuman JS (2000) Antiglaucoma medications. A review of safety and tolerability issues related to their use. Clin Ther 22:167–208CrossRefPubMed Schuman JS (2000) Antiglaucoma medications. A review of safety and tolerability issues related to their use. Clin Ther 22:167–208CrossRefPubMed
35.
go back to reference Shrum KR, Hattenhauer MG, Hodge D (2000) Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129:83–86CrossRefPubMed Shrum KR, Hattenhauer MG, Hodge D (2000) Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129:83–86CrossRefPubMed
36.
go back to reference Stewart WC, Osterman J (1998) Serum lipid physiology and the influence of glaucoma medications. Surv Ophthalmol 43:233–244CrossRefPubMed Stewart WC, Osterman J (1998) Serum lipid physiology and the influence of glaucoma medications. Surv Ophthalmol 43:233–244CrossRefPubMed
37.
go back to reference Thorburn W, Lindblom B (1983) Survival time among patients with glaucomatous visual field defects. Acta Ophthalmol Scand 61:728–730 Thorburn W, Lindblom B (1983) Survival time among patients with glaucomatous visual field defects. Acta Ophthalmol Scand 61:728–730
38.
go back to reference Tielsch Jm, Katz J, Sommer A et al. (1995) Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 113:216–221PubMed Tielsch Jm, Katz J, Sommer A et al. (1995) Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 113:216–221PubMed
39.
go back to reference Wu SY, Nemesure B, Leske MC (2001) Observed versus indirect estimates of incidence of open-angle glaucoma. Am J Epidemiol 153:184–187CrossRefPubMed Wu SY, Nemesure B, Leske MC (2001) Observed versus indirect estimates of incidence of open-angle glaucoma. Am J Epidemiol 153:184–187CrossRefPubMed
Metadata
Title
Glaucoma and mortality
Authors
Kirsti Grødum
Anders Heijl
Bo Bengtsson
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 5/2004
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-004-0858-2

Other articles of this Issue 5/2004

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2004 Go to the issue

Announcements

May 2004